Skip to main content
. 2023 Feb 15;23:27. doi: 10.1186/s12935-023-02866-1

Fig. 1.

Fig. 1

CCL14-AS is downregulated in CRC and associated with favorable prognosis. A The cancer-related, metastasis-related and survival-related lncRNAs were selected from the TCGA datasets. B Analysis of CCL14-AS expression in CRC compared with normal tissues in TCGA-COADREAD. C CCL14-AS expressions in paired CRC cancer tissues and adjacent normal tissues in TCGA-COADREAD were compared. D CCL14-AS expression in normal, N0 Stage CRC samples and N1-2 Stage CRC samples in TCGA-COADREAD was also compared. E Kaplan–Meier analysis of overall survival in all patients with CRC according to CCL14-AS expression in TCGA datasets (log-rank test P = 0.035). F qRT-PCR was performed to determine relative CCL14-AS RNA level in paired CRC cancer tissues and adjacent normal tissues. GI FISH assay was conducted to determine the expression of CCL14-AS in 96 paraffin-embedded CRC tissues. G Representative FISH images are shown. CCL14-AS‑stained are green, DAPI‑stained nuclei are blue. Scale bar: 100 μm. H Graphical illustration of statistical CCL14-AS distribution in CRC patients. I Kaplan–Meier analysis of overall survival rate according to high, medium or low CCL14-AS expression. * p < 0.05, ** p < 0.01, *** p < 0.001